Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure.
Publication
, Journal Article
Joynt, KE; Gattis, WA; Hasselblad, V; Fuzaylov, SY; Serebruany, VL; Gurbel, PA; Gaulden, LH; Felker, GM; Whellan, DJ; O'Connor, CM
Published in: Am J Cardiol
March 15, 2004
C-reactive protein (CRP) levels were measured in a cohort of 96 outpatients with heart failure. Baseline angiotensin-converting enzyme inhibitor plus beta-blocker use were associated with lower levels of CRP; no relation was found between CRP levels and aspirin or statin use.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Am J Cardiol
DOI
ISSN
0002-9149
Publication Date
March 15, 2004
Volume
93
Issue
6
Start / End Page
783 / 785
Location
United States
Related Subject Headings
- Prospective Studies
- Pilot Projects
- North Carolina
- Middle Aged
- Male
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Heart Failure
- Female
- Cardiovascular System & Hematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Joynt, K. E., Gattis, W. A., Hasselblad, V., Fuzaylov, S. Y., Serebruany, V. L., Gurbel, P. A., … O’Connor, C. M. (2004). Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure. Am J Cardiol, 93(6), 783–785. https://doi.org/10.1016/j.amjcard.2003.12.010
Joynt, Karen E., Wendy A. Gattis, Vic Hasselblad, Sergey Y. Fuzaylov, Victor L. Serebruany, Paul A. Gurbel, Laura H. Gaulden, G Michael Felker, David J. Whellan, and Christopher M. O’Connor. “Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure.” Am J Cardiol 93, no. 6 (March 15, 2004): 783–85. https://doi.org/10.1016/j.amjcard.2003.12.010.
Joynt KE, Gattis WA, Hasselblad V, Fuzaylov SY, Serebruany VL, Gurbel PA, et al. Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure. Am J Cardiol. 2004 Mar 15;93(6):783–5.
Joynt, Karen E., et al. “Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure.” Am J Cardiol, vol. 93, no. 6, Mar. 2004, pp. 783–85. Pubmed, doi:10.1016/j.amjcard.2003.12.010.
Joynt KE, Gattis WA, Hasselblad V, Fuzaylov SY, Serebruany VL, Gurbel PA, Gaulden LH, Felker GM, Whellan DJ, O’Connor CM. Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure. Am J Cardiol. 2004 Mar 15;93(6):783–785.
Published In
Am J Cardiol
DOI
ISSN
0002-9149
Publication Date
March 15, 2004
Volume
93
Issue
6
Start / End Page
783 / 785
Location
United States
Related Subject Headings
- Prospective Studies
- Pilot Projects
- North Carolina
- Middle Aged
- Male
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Heart Failure
- Female
- Cardiovascular System & Hematology